Home > Healthcare > Medical Devices > Medical Supplies > organ preservation solution market
Get a free sample of Organ Preservation Solution Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Organ Preservation Solution Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The market is witnessing intense competition with diverse range of players aiming to innovate, enhance product offerings, and expand their global footprint. Waters Medical Systems LLC, Xvivo Perfusion AB, Transmedics, Inc. are prominent players in this market. Market players are vying for a competitive edge by addressing the evolving needs of organ transplantation and offering solutions that enhance organ viability, ease of use, and patient outcomes.
Market players operating in the organ preservation solution industry are as mentioned below:
University of Wisconsin (UW) segment accounted for 38.2% share of the organ preservation solution industry in 2022 and is estimated to record substantial growth through 2032 attributed to the presence of established distribution networks for facilitating its accessibility to transplantation centers.
Organ preservation solution industry size reached USD 256.1 million in 2022 and is projected to expand at 6.8% CAGR from 2023-2032 driven by the rising number of organ transplantation procedures coupled with the massive healthcare investments.
Some major organ preservation solution firms are Waters Medical Systems LLC, Xvivo Perfusion AB, Transmedics, Inc., Preservation Solutions, Inc., Paragonix Technologies, Inc., Organox Limited, Dr. Franz Koehler Chemie GmbH, Accord Healthcare Inc., and Shanghai Genext Medical Technology.
North America organ preservation solution market was worth USD 103 million in revenue in 2022 and is anticipated to reach USD 196.5 million by 2032 driven by the well-developed and advanced healthcare infrastructure.